Allergan recalls birth control pills over packaging error

Allergan recalls birth control pills over packaging error

Allergan recalls birth control pills over packaging error

- The FDA is issuing a recall alert for the TAYTULLA birth control due to a packaging error that could result in an unintended pregnancy.

Pharmaceutical company Allergan issued a voluntary nationwide recall Tuesday on nearly 170,000 sample packs of the birth control Taytulla.

The company says four placebo pills were placed out of order in the Taytulla packs. Modern birth control pills that are lower in estrogen have fewer side effects than past oral contraceptives. Instead, the faulty pack had four maroon placebos at the start of the treatment. Affected packs of Taytulla birth control came in a 28-count blister card that is supposed to have 24 "active" pink capsules and four maroon placebo capsules. Allergan said that the incorrect order is significant enough to cause pregnancy.

Consumers who have the sample pack product with the associated lot number should notify their physician to arrange a return. May 2019 since August 27, 2017, and are concerned that you may be impacted by this issue, please consult with your physician.

According to STAT News, this is the only lot of sample packs that have been identified as incorrectly packaged.

Allergan said patients should contact they doctors if they have any concerns, or they can call the company at: 1-800-678-1605.

The recall issued in the USA market is of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy.

Related news